Hackensack Meridian Health clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 113 studies whose lead sponsor is Hackensack Meridian Health. 28 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 23, 2026.
Keep track of what changes. Save the Hackensack Meridian Health studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Hackensack Meridian Health leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 113. Browse all 113 →
- Increasing Engagement With Digital Behavioral HealthNot yet recruitingNCT07837089Not applicable
- Remote Monitoring Using a Digital PlatformRecruitingNCT07837102Not applicable
- Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple MyelomaRecruitingNCT03909412Phase 1
- A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple MyelomaRecruitingNCT04661137Phase 2
- Positive Affirmations and Preoperative AnxietyNot yet recruitingNCT07832253Not applicable
- Post Operative Urinary Retention (POUR) Following Thoracic Oncological SurgeryRecruitingNCT05657990Early Phase 1
- Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)RecruitingNCT05651945Not applicable
- Leveraging the Emergency Department (LEAD) StudyRecruitingNCT06605534Not applicable
- OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum DepressionRecruitingNCT06991166Not applicable
- Witness Project LungNot yet recruitingNCT07792824Not applicable
- Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant BiomarkersNot yet recruitingNCT06987708Not applicable
- ED Medicaid SupportRecruitingNCT07594782Not applicable
- Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant AdministrationRecruitingNCT07442669Not applicable
- Battlefield Acupressure for Acute Back Pain Management in the Emergency DepartmentNot yet recruitingNCT07771686Not applicable
- Support for Cancer Patients Awaiting NewsRecruitingNCT06199570Not applicable
- Headache Diary for Migraine PatientsEnrolling by invitationNCT07698249Not applicable
- Emotional Awareness Therapy StudyRecruitingNCT07624825Not applicable
- Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving Psychological Health in People With Brain InjuryRecruitingNCT07436754Not applicable
- Post-operative Urinary Retention (POUR) Following Thoracic SurgeryRecruitingNCT03609580Phase 1/2
- ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer RosettesRecruitingNCT04794686
- Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral AnticoagulantNot yet recruitingNCT07621796Phase 3
- CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and ManagementRecruitingNCT06804395
- Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic SarcomaRecruitingNCT05726383Phase 2
- Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm NeonatesRecruitingNCT07216053
- Implementing Mental Health Programs Across Communities in Iowa & Indiana for TransformationEnrolling by invitationNCT06575894Not applicable
- Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyRecruitingNCT06798558Phase 2
- Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland TreatmentRecruitingNCT07011342Not applicable
- Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme MalignanciesRecruitingNCT07214688Phase 2
- Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With ImmunotherapyTerminatedNCT05715229Phase 2
- Transitions of Care Clinic (TOCC)TerminatedNCT06937827Not applicable
- Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell LymphomaActive, not recruitingNCT02446236Phase 1
- Prostasomes as Diagnostic Tool for Prostate Cancer DetectionSuspendedNCT03694483
- A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple MyelomaActive, not recruitingNCT01297764Phase 1/2
- Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic PatientsCompletedNCT05776953Phase 4
- Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple MyelomaSuspendedNCT05199311Phase 1/2
- Fluoroquinolone Resistance Prevalence StudyTerminatedNCT05824689
- AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord AllograftActive, not recruitingNCT04263025Phase 2/3
- Culturally Tailored Diabetes Education on Self-Management of Adult Hispanic Males With Type 2 Diabetes MellitusTerminatedNCT06897618Not applicable
- Ceftriaxone for Post-Treatment Lyme DiseaseWithdrawnNCT06785402Phase 1/2
- Endometrial Cell Collection With the PadKitCompletedNCT06464107Not applicable
- Allogeneic Hematopoietic Stem Cell Transplantation for Multiple MyelomaCompletedNCT01453101Phase 2
- In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and SirolimusTerminatedNCT01453140Phase 1/2
- Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCLCompletedNCT01241734Phase 1/2
- A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531CompletedNCT01813227Phase 2
- A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 DiabetesCompletedNCT02624804Phase 1
- Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus LenalidomideCompletedNCT01723839Phase 2
- Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body IrradiationTerminatedNCT01366612Phase 3
- Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant RecurrenceTerminatedNCT02681302Phase 1/2
- Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing RegimensCompletedNCT01502085Phase 1/2
- Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCTCompletedNCT01242267Phase 1/2